July 18, 2017Consulting Agreement • August 9th, 2017 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
This letter confirms the agreement (“Agreement”) between you and Aeglea Development Company, Inc. and its parent company Aeglea BioTherapeutics, Inc. (together, the “Company”) concerning the terms of your resignation and offers you the separation compensation we discussed in exchange for a general release of claims and covenant not to sue.
